Study for the Clinical Research and Ethical Considerations Test. Enhance your understanding with multiple choice questions covering essential ethical guidelines and research methodologies. Prepare effectively for your test!

Multiple Choice

Phase II trial characteristics include which of the following sets?

Phase II trials are designed to look for signals of efficacy in patients who actually have the disease, while continuing to assess safety and tolerability. They typically enroll around a medium-sized group, often about a hundred participants, and use a randomized, double-blind, placebo- or active-controlled design to provide reliable evidence about whether the drug works and how safe it is at the studied doses. This setup helps refine dose and gather more robust efficacy data before moving to a larger Phase III trial. Other patterns fit different stages: healthy volunteers and long-term safety studies point to Phase I safety work in humans; studies in animals or aiming for market approval with open-label designs align more with preclinical work or late-stage development, not Phase II.

Phase II trials are designed to look for signals of efficacy in patients who actually have the disease, while continuing to assess safety and tolerability. They typically enroll around a medium-sized group, often about a hundred participants, and use a randomized, double-blind, placebo- or active-controlled design to provide reliable evidence about whether the drug works and how safe it is at the studied doses. This setup helps refine dose and gather more robust efficacy data before moving to a larger Phase III trial.

Other patterns fit different stages: healthy volunteers and long-term safety studies point to Phase I safety work in humans; studies in animals or aiming for market approval with open-label designs align more with preclinical work or late-stage development, not Phase II.